Cargando…
Vitamin A and Hydrochlorothiazide Causing Severe Hypercalcemia in a Patient With Primary Hyperparathyroidism
Objective. To report a case of severe hypercalcemia, exacerbated by vitamin A supplementation and hydrochlorothiazide, in a patient with primary hyperparathyroidism. Methods. Clinical and laboratory findings are presented along with response to therapy. Results. A 68-year-old white female presented...
Autores principales: | Varghese, Ron T., Khasawneh, Khaled, Desikan, Raman K., Subramaniam, Anandaraj, Weaver, Todd, Nair, Ganesh K. V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350155/ https://www.ncbi.nlm.nih.gov/pubmed/30791717 http://dx.doi.org/10.1177/2324709618823805 |
Ejemplares similares
-
Denosumab for management of severe hypercalcemia in primary hyperparathyroidism
por: Eremkina, Anna, et al.
Publicado: (2020) -
Concurrent Primary Hyperparathyroidism and Sarcoidosis in a Patient With Severe Hypercalcemia
por: Ayyad, Mohammed, et al.
Publicado: (2023) -
Lithium-induced Hyperparathyroidism and Hypercalcemia
por: Naramala, Srikanth, et al.
Publicado: (2019) -
Causes of hypercalcemia in renal transplant recipients: persistent hyperparathyroidism and others
por: Moyses-Neto, M., et al.
Publicado: (2021) -
Management of Primary Hyperparathyroidism With Severe Hypercalcemia During the COVID-19 Pandemic
por: Alfadhli, Eman M.
Publicado: (2021)